Deep Brain Stimulators Market Worth $1.6 Billion by 2020: Grand View Research, Inc.
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 12/23/15 -- Global is expected to reach USD 1,592.9 million by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of Parkinson''s disease coupled with rising demand for cost effective & minimally invasive surgical procedures are the factors attributing towards the growth of deep brain stimulators market. According to statistics published by Parkinson''s Disease Foundation, approximately 10 million people were suffering from this disease in 2010 and the number was anticipated to grow manifolds over the forecast period thereby contributing to the overall industry growth.
The significant increase in the adoption of DBS by neurologist for the treatment of Parkinson''s disease, essential tremors, obsessive compulsive disorder and Dystonia is expected to drive the market growth in coming years. Pending commercialization approval from the U.S. FDA for use of DBS in treatment of refractory epilepsy is also expected to boost the market growth in near future. Furthermore, introduction of technologically advanced selective current steering and fractionation of electric current is further expected to enhance the usage of deep brain stimulators in the near future.
DBS found wide application in Parkinson''s disease treatment and is expected to grow at CAGR of above 18.0% due to associated benefits such as fewer side effects, improvised motor symptoms for longer time period and tracking of momentary fluctuations. In addition, shifting of preference from conventional oral medications to DBS, due to drug resistant nature of Parkinson''s disease is further expected to increase adoption of DBS over the forecast period.
Obsessive compulsive disorder followed Parkinson''s disease in terms of revenue share due to failure of conventional serotonin reuptake inhibitors (SSRi) treatment and offered benefits such as adjustable & reversible stimulations, and nondestructive nature of treatment.
North America held the dominant share, accounting for over 50.0% in 2013. Presence of sophisticated healthcare infrastructure, increasing awareness levels of patients and healthcare personnel and supportive reimbursement policies are some of the key reasons driving growth of deep brain stimulators regional industry.
Asia Pacific region is expected to be fastest growing market for DBS and grow at CAGR of over 18.0% during the forecast period. Constantly improving healthcare facility, presence of high unmet needs and rising expenditure levels are accounted for its significant growth.
Key players of deep brain stimulators industry include Aleva Neurotherapeutics SA, Boston Scientific Corporation, St. Jude Medical, and Medtronic Plc. Increasing clinical applications of DBS systems and extensive R&D pertaining to development of advanced technology are the factors propelling industrial growth. Players are adopting competitive strategy such as new product development for sustaining the competition.
Grand View Research has segmented the global deep brain stimulators market on the basis of application and region:
Pain Management
Epilepsy
Essential Tremor
Obsessive Compulsive Disorder (OCD)
Depression
Dystonia
Parkinson''s Disease
Others
North America
U.S.
Europe
Germany
UK
Asia Pacific
Japan
RoW
Brazil
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Sherry James
Corporate Sales Specialist
USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:
Web:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 23.12.2015 - 05:30 Uhr
Sprache: Deutsch
News-ID 1406156
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN FRANCISCO, CA
Phone:
Kategorie:
Hospitals, Facilities and Providers
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 330 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Deep Brain Stimulators Market Worth $1.6 Billion by 2020: Grand View Research, Inc.
"
steht unter der journalistisch-redaktionellen Verantwortung von
Grand View Research, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
